The varicella vaccine. Prevention of herpes zoster (Q41150983)

27 September 2017

1 reference

title

The varicella vaccine. Prevention of herpes zoster (English)

1 reference

27 September 2017

Levin MJ

1

1 reference

PubMed ID

8856358

27 September 2017

Hayward AR

series ordinal

2

1 reference

27 September 2017

1 September 1996

1 reference

Infectious Disease Clinics of North America

27 September 2017

1 reference

27 September 2017

10

1 reference

27 September 2017

3

1 reference

27 September 2017

657-675

1 reference

Immunologic Evidence of Reinfection with Varicella-Zoster Virus

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Zoster sine herpete of the trigeminal nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Hypotheses on the pathogenesis of herpes zoster-associated pain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Enhancement of Varicella-Zoster-Specific Immune Responses in the Elderly by Boosting with Varicella Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Antigen presentation to cytotoxic T lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The outcome of patients with herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

NIH conference. Herpes zoster-varicella infections in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

A controlled trial of acyclovir for chickenpox in normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

More on acyclovir for chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Zoster sine herpete causing acute trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Taxonomy and mechanisms of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

A viral inhibitor of peptide transporters for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The epidemiology of varicella–zoster virus infections: the influence of varicella on the prevalence of herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Antibody Responses to Varicella-Zoster Virus and the Role of Antibody in Host Defense

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immunization of healthy adults with live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Live Attenuated Varicella Vaccine: Protection in Healthy Adults Compared with Leukemic Children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Zoster sine herpete, a clinical variant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Painful neuropathy: altered central processing maintained dynamically by peripheral input

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Activation of murine T-cells via phospholipase-C gamma 1-associated protein tyrosine phosphorylation is reduced with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Biologic and Biophysical Markers of a Live Varicella Vaccine Strain (Oka): Identification of Clinical Isolates from Vaccine Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Lymphocyte responses to varicella zoster virus in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus-specific immunity after herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Clinical application of responder cell frequency estimates with four years of follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus RNA in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immune response of elderly individuals to a live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

A Longitudinal Study of Varicella-Zoster Virus Infections in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Area under the curve: a metric for patient subjective responses in episodic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

How do CTL control virus infections? Evidence for prelytic halt of herpes simplex

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Lack of effect of acyclovir on postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus transcription in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Selective decline in cellular immune response to varicella-zoster in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Somatosensory findings in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Pain and allodynia in postherpetic neuralgia: role of somatic and sympathetic nervous systems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Population-based study of herpes zoster and its sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Accessory Function and Properties of Monocytes from Healthy Elderly Humans for T Lymphocyte Responses to Mitogen and Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Geriatric herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Biology of human TH1 and TH2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Assessment of alloreactive T cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T cell-mediated rejection response declines with advanced age

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Immune responses to varicella zoster virus infections in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Racial differences in the occurrence of herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Physiological T-cell death: susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Subclinical Varicella-Zoster Virus Viremia, Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral Antigens after Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

Ultraviolet-B irradiation alters cytokine production by immune lymphocytes in herpes simplex virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970319-6

7 January 2021

10.1016/S0891-5520(05)70319-6

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8856358